News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
289,655 Results
Type
Article (15491)
Company Profile (299)
Press Release (273861)
Multimedia
Podcasts (100)
Webinars (12)
Section
Business (80332)
Career Advice (167)
Deals (13463)
Drug Delivery (46)
Drug Development (50940)
Employer Resources (31)
FDA (5916)
Job Trends (5218)
News (145923)
Policy (10153)
Tag
2027 BioMidwest Elite (1)
2027 BioMidwest Standard (1)
2027 Bio NC Standard (2)
2027 Biotech Bay Elite (1)
2027 Biotech Bay Standard (1)
2027 Biotech Beach Elite (1)
2027 Genetown Elite (2)
2027 Genetown Standard (4)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (4)
Academia (1015)
Accelerated approval (29)
Adcomms (14)
Allergies (104)
Alliances (21892)
ALS (166)
Alzheimer's disease (1138)
Antibody-drug conjugate (ADC) (398)
Approvals (6204)
Artificial intelligence (365)
Autoimmune disease (255)
Automation (11)
Bankruptcy (105)
Best Places to Work (4585)
BIOSECURE Act (6)
Biosimilars (122)
Biotechnology (229)
Bladder cancer (121)
Brain cancer (58)
Breast cancer (425)
Cancer (4025)
Cardiovascular disease (293)
Career advice (156)
Career pathing (10)
CAR-T (278)
CDC (8)
Celiac Disease (1)
Cell therapy (741)
Cervical cancer (23)
Clinical research (44966)
Collaboration (1451)
Company closure (3)
Compensation (756)
Complete response letters (57)
COVID-19 (1143)
CRISPR (123)
C-suite (770)
Cystic fibrosis (121)
Data (5803)
Denatured (20)
Depression (115)
Dermatology (57)
Diabetes (316)
Diagnostics (1482)
Digital health (19)
Diversity (6)
Diversity, equity & inclusion (9)
Drug discovery (263)
Drug pricing (53)
Drug shortages (3)
Duchenne muscular dystrophy (275)
Earnings (32837)
Editorial (33)
Employer branding (4)
Employer resources (29)
Events (53697)
Executive appointments (701)
FDA (8113)
Fibrodysplasia Ossificans Progressiva (6)
Friedreich's ataxia (17)
Frontotemporal dementia (31)
Funding (1203)
Gene editing (251)
Generative AI (35)
Gene therapy (617)
GLP-1 (562)
Government (1208)
Grass and pollen (3)
Guidances (176)
Healthcare (6763)
HIV (27)
Huntington's disease (51)
Idiopathic pulmonary fibrosis (2)
IgA nephropathy (92)
Immunology and inflammation (235)
Immuno-oncology (82)
Indications (131)
Infectious disease (1295)
Inflammatory bowel disease (183)
Inflation Reduction Act (10)
Influenza (55)
Intellectual property (204)
Interviews (19)
IPO (7397)
IRA (13)
Job creations (875)
Job search strategy (133)
JPM (41)
Kidney cancer (9)
Labor market (31)
Layoffs (256)
Leadership (14)
Legal (1419)
Liver cancer (47)
Longevity (24)
Lung cancer (538)
Lymphoma (301)
Machine learning (33)
Management (7)
Manufacturing (527)
MASH (162)
Medical device (2711)
Medtech (2733)
Mergers & acquisitions (6792)
Metabolic disorders (902)
mRNA (160)
Multiple sclerosis (124)
NASH (15)
Neurodegenerative disease (325)
Neuropsychiatric disorders (82)
Neuroscience (2309)
Neurotech (1)
NextGen: Class of 2026 (2064)
Non-profit (900)
Now hiring (40)
Obesity (400)
Opinion (145)
Ovarian cancer (186)
Pain (133)
Pancreatic cancer (231)
Parkinson's disease (301)
Partnered (13)
Patents (388)
Patient recruitment (503)
Peanut (49)
People (27327)
Pharmaceutical (42)
Pharmacy benefit managers (6)
Phase 1 (15958)
Phase 2 (20936)
Phase 3 (13175)
Pipeline (5965)
Policy (107)
Postmarket research (853)
Preclinical (6792)
Press Release (39)
Prostate cancer (200)
Psychedelics (58)
Radiopharmaceuticals (282)
Rare diseases (888)
Real estate (1462)
Recruiting (12)
Regulatory (10601)
Reports (20)
Research institute (1030)
Resumes & cover letters (20)
Rett syndrome (35)
RNA editing (28)
RSV (24)
Schizophrenia (146)
Series A (235)
Series B (161)
Service/supplier (1)
Sickle cell disease (107)
Special edition (20)
Spinal muscular atrophy (125)
Sponsored (17)
Startups (2047)
State (1)
Stomach cancer (5)
Supply chain (38)
Tariffs (19)
The Weekly (78)
Vaccines (397)
Venture capital (88)
Weight loss (214)
Women's health (45)
Worklife (2)
Date
Today (15)
Last 7 days (423)
Last 30 days (1870)
Last 365 days (17885)
2026 (8381)
2025 (18169)
2024 (20652)
2023 (22540)
2022 (26999)
2021 (27997)
2020 (23519)
2019 (16381)
2018 (11831)
2017 (13870)
2016 (11917)
2015 (14390)
2014 (10416)
2013 (7490)
2012 (7532)
2011 (7614)
2010 (7428)
Location
Africa (156)
Alabama (72)
Alaska (3)
Arizona (84)
Arkansas (6)
Asia (18742)
Australia (3207)
California (8586)
Canada (2190)
China (1016)
Colorado (305)
Connecticut (322)
Delaware (294)
Europe (40325)
Florida (1104)
Georgia (251)
Hawaii (2)
Idaho (18)
Illinois (518)
India (46)
Indiana (198)
Iowa (10)
Japan (298)
Kansas (84)
Kentucky (11)
Louisiana (14)
Maine (12)
Maryland (885)
Massachusetts (6848)
Michigan (128)
Minnesota (308)
Mississippi (3)
Missouri (40)
Montana (17)
Nebraska (6)
Nevada (47)
New Hampshire (22)
New Jersey (1956)
New Mexico (13)
New York (2131)
North Carolina (1003)
North Dakota (8)
Northern California (4349)
Ohio (216)
Oklahoma (11)
Oregon (23)
Pennsylvania (1583)
Puerto Rico (11)
Rhode Island (27)
South America (219)
South Carolina (12)
Southern California (3440)
Tennessee (50)
Texas (1175)
United States (28436)
Utah (118)
Virginia (176)
Washington D.C. (37)
Washington State (719)
West Virginia (1)
Wisconsin (57)
289,655 Results for "crispr therapeutics".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
CRISPR Therapeutics to Participate in Upcoming June 2026 Investor Conferences
May 28, 2026
·
1 min read
Gene therapy
Intellia’s CRISPR Gene Therapy Free To Move Forward After FDA Fully Lifts Hold
The FDA last October paused Intellia Therapeutics’ late-stage CRISPR studies after detecting life-threatening enzyme elevations in one patient, who died a few days later.
March 3, 2026
·
2 min read
·
Tristan Manalac
Press Releases
CRISPR Therapeutics to Present at the Bank of America Securities 2026 Global Healthcare Conference
May 6, 2026
·
1 min read
Gene therapy
Vertex, CRISPR Set Lofty Goal for Casgevy Gene Therapy as Patient Starts Ramp
Following over a year of slow uptake, Vertex Pharmaceuticals and CRISPR Therapeutics expect Casgevy revenues to nearly triple in 2026, as patient access to the sickle cell disease and beta thalassemia gene therapy grows.
February 13, 2026
·
3 min read
·
Dan Samorodnitsky
Press Releases
CRISPR Therapeutics Provides Business Update and Reports First Quarter 2026 Financial Results
May 4, 2026
·
18 min read
Press Releases
CRISPR Therapeutics to Present at the 25th Annual Needham Virtual Healthcare Conference
April 7, 2026
·
1 min read
Press Releases
Scribe Therapeutics to Highlight Engineered CRISPR Platform Advances and Lead Cardiometabolic Pipeline at ASGCT and EAS Congress 2026
April 30, 2026
·
3 min read
Press Releases
CRISPR Therapeutics Announces Proposed Convertible Senior Notes Offering
March 10, 2026
·
4 min read
Press Releases
CRISPR Therapeutics Prices Upsized Convertible Senior Notes Offering
March 11, 2026
·
7 min read
Press Releases
Scribe Therapeutics Reports Preclinical Data at ASGCT 2026 Demonstrating Enhanced Potency and Specificity of Engineered CRISPR Technologies for Epigenetic Silencing and Gene Editing
May 18, 2026
·
7 min read
1 of 28,966
Next
